Federated Hermes, Inc. Exact Sciences Corp Transaction History

Federated Hermes, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$41.33 - $74.26 $12.8 Million - $23.1 Million	-310,740 Reduced 55.67%	247,491 $10.5 Million
Q1 2024 May 14, 2024	BUY	$56.27 - $73.77 $7.26 Million - $9.51 Million	128,939 Added 30.04%	558,231 $38.6 Million
Q4 2023 Jan 31, 2024	BUY	$59.06 - $75.72 $13.3 Million - $17.1 Million	225,211 Added 110.35%	429,292 $31.8 Million
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $10.2 Million - $15.4 Million	155,386 Added 319.1%	204,081 $13.9 Million
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $3.05 Million - $4.63 Million	48,695 New	48,695 $4.57 Million
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $6.36 Million - $13.6 Million	178,559 New	178,559 $7.03 Million
Q1 2018 May 09, 2018	SELL	$39.82 - $57.53 $1.76 Million - $2.55 Million	-44,260 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $1.22 Million - $1.59 Million	-26,245 Reduced 37.22%	44,260 $0
Q3 2017 Nov 13, 2017	BUY	$37.05 - $47.12 $2.61 Million - $3.32 Million	70,505	70,505 $3.32 Million

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.